Over a period of 10 years, the continuous monitoring of cardiac iron levels and a tailored chelation therapy allowed a reduction of myocardial iron overload (MIO) in the 70% of patients with thalassemia major (TM) enrolled in the MIOT (Myocardial Iron Overload in Thalassemia) Network. A consequent improvement of cardiac function and a reduction of heart failure were detected. So, a national networking was effective in improving the care and reducing cardiac outcomes of TM patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords